CSB Genomics Overview
- Status
-
Acquired/Merged
- Latest Deal Type
-
Early Stage VC
- Latest Deal Amount
-
$77.5K
- Investors
-
1
CSB Genomics General Information
Description
Developer of treatment for non-invasive cancer designed to provide personalized anticancer drug therapy for non-invasive cancer diseases.
Contact Information
Ownership Status
Acquired/Merged
(Operating Subsidiary)
(Operating Subsidiary)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Parent Company
Primary Office
- Moscow
- Russia
CSB Genomics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Early Stage VC | 30-Sep-2016 | $77.5K | 000.00 | Completed | Generating Revenue | |
| 1. Merger/Acquisition | 01-Oct-2015 | Completed | Generating Revenue |
CSB Genomics Executive Team (1)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Vladislav Mileiko | Chief Executive Officer |